| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |